A citation-based method for searching scientific literature

Robert J Motzer, Bernard Escudier, David F McDermott, Saby George, Hans J Hammers, Sandhya Srinivas, Scott S Tykodi, Jeffrey A Sosman, Giuseppe Procopio, Elizabeth R Plimack, Daniel Castellano, Toni K Choueiri, Howard Gurney, Frede Donskov, Petri Bono, John Wagstaff, Thomas C Gauler, Takeshi Ueda, Yoshihiko Tomita, Fabio A Schutz, Christian Kollmannsberger, James Larkin, Alain Ravaud, Jason S Simon, Li-An Xu, Ian M Waxman, Padmanee Sharma. N Engl J Med 2015
Times Cited: 3277



Edward B Garon, Naiyer A Rizvi, Rina Hui, Natasha Leighl, Ani S Balmanoukian, Joseph Paul Eder, Amita Patnaik, Charu Aggarwal, Matthew Gubens, Leora Horn, Enric Carcereny, Myung-Ju Ahn, Enriqueta Felip, Jong-Seok Lee, Matthew D Hellmann, Omid Hamid, Jonathan W Goldman, Jean-Charles Soria, Marisa Dolled-Filhart, Ruth Z Rutledge, Jin Zhang, Jared K Lunceford, Reshma Rangwala, Gregory M Lubiniecki, Charlotte Roach, Kenneth Emancipator, Leena Gandhi. N Engl J Med 2015
Times Cited: 3474




List of shared articles



Times cited



The Role of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review and Pooled Analysis of 2,402 Patients.
Ioannis A Ziogas, Alexandros P Evangeliou, Dimitrios Giannis, Muhammad H Hayat, Konstantinos S Mylonas, Samer Tohme, David A Geller, Nahel Elias, Lipika Goyal, Georgios Tsoulfas. Oncologist 2021
4

Z-guggulsterone induces PD-L1 upregulation partly mediated by FXR, Akt and Erk1/2 signaling pathways in non-small cell lung cancer.
Han Tian, Yanni Gui, Yuanhui Wei, Bin Shang, Jian Sun, Shan Ma, Wenjie You, Shujuan Jiang. Int Immunopharmacol 2021
0

Combination of radiation therapy for brain metastasis and anti-PD-1/PD-L1 treatment in non-small cell lung cancer: two cases and review of the literature.
Olga Nigro, Alessandro Tuzi, Andrea Coppola, Tiziana Tartaro, Claudio Chini, Graziella Pinotti. Anticancer Drugs 2021
0

Neurological complications of immune checkpoint inhibitor cancer immunotherapy.
Cecilia Zivelonghi, Anastasia Zekeridou. J Neurol Sci 2021
0

Current strategies for intratumoural immunotherapy - Beyond immune checkpoint inhibition.
Jianda Yuan, Anuradha Khilnani, Joshua Brody, Robert H I Andtbacka, Siwen Hu-Lieskovan, Jason J Luke, Adi Diab, Aurelien Marabelle, Alexandra Snyder, Z Alexander Cao,[...]. Eur J Cancer 2021
0

Immune landscape and therapeutic strategies: new insights into PD-L1 in tumors.
Yuan Wei, Xiao Xiao, Xiang-Ming Lao, Limin Zheng, Dong-Ming Kuang. Cell Mol Life Sci 2021
1

Targeting the PD-1/PD-L1 pathway in glioblastoma multiforme: Preclinical evidence and clinical interventions.
Abolfazl Maghrouni, Maryam Givari, Mohammad Jalili-Nik, Hamid Mollazadeh, Bahram Bibak, Mohammad Montazami Sadeghi, Amir R Afshari, Thomas P Johnston, Amirhossein Sahebkar. Int Immunopharmacol 2021
3

Overview of checkpoint inhibitor pneumonitis: incidence and associated risk factors.
Yuji Shibata, Shuji Murakami, Terufumi Kato. Expert Opin Drug Saf 2021
0